MLTX
Price
$18.27
Change
+$0.40 (+2.24%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.34B
70 days until earnings call
Intraday BUY SELL Signals
NUVB
Price
$4.72
Change
-$0.18 (-3.67%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.73B
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs NUVB

Header iconMLTX vs NUVB Comparison
Open Charts MLTX vs NUVBBanner chart's image
MLTX vs NUVB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLTX vs. NUVB commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (MLTX: $18.27 vs. NUVB: $4.90)
Brand notoriety: MLTX and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 53% vs. NUVB: 109%
Market capitalization -- MLTX: $1.34B vs. NUVB: $1.73B
MLTX [@Biotechnology] is valued at $1.34B. NUVB’s [@Biotechnology] market capitalization is $1.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, both MLTX and NUVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 3 bearish.
  • NUVB’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -0.76% price change this week, while NUVB (@Biotechnology) price change was +4.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.85%. For the same industry, the average monthly price growth was -4.25%, and the average quarterly price growth was +0.68%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 12, 2026.

NUVB is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.73B) has a higher market cap than MLTX($1.35B). MLTX YTD gains are higher at: 38.619 vs. NUVB (-45.313). NUVB has higher annual earnings (EBITDA): -123.69M vs. MLTX (-219.85M). NUVB has more cash in the bank: 534M vs. MLTX (394M). NUVB has less debt than MLTX: NUVB (57.2M) vs MLTX (75.7M). NUVB has higher revenues than MLTX: NUVB (143M) vs MLTX (0).
MLTXNUVBMLTX / NUVB
Capitalization1.35B1.73B78%
EBITDA-219.85M-123.69M178%
Gain YTD38.619-45.313-85%
P/E RatioN/AN/A-
Revenue0143M-
Total Cash394M534M74%
Total Debt75.7M57.2M132%
TECHNICAL ANALYSIS
Technical Analysis
MLTXNUVB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
NUVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECCPX48.17N/A
N/A
Eaton Vance Tax-Managed Multi-Cap Gr C
BALFX41.06N/A
N/A
American Funds American Balanced F1
MWEGX32.64N/A
N/A
MFS Global Equity R1
JNEMX23.89N/A
N/A
JPMorgan International Equity R6
BDAFX34.59-0.34
-0.97%
Baron Durable Advantage Retail

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with NRIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-1.21%
NRIX - NUVB
44%
Loosely correlated
-5.92%
VCYT - NUVB
40%
Loosely correlated
-0.79%
IBIO - NUVB
37%
Loosely correlated
-6.88%
ANNX - NUVB
37%
Loosely correlated
-5.82%
MLTX - NUVB
37%
Loosely correlated
-5.10%
More